Dr. Martens (LON:DOCS) Trading 0.7% Higher – Should You Buy?

Dr. Martens plc (LON:DOCS) traded up 0.7% on Thursday . The company traded as high as GBX 60 ($0.81) and last traded at GBX 59.95 ($0.81). 1,098,886 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 2,196,119 shares. The stock had previously closed at GBX 59.55 ($0.81).

Analysts Set New Price Targets

Separately, Royal Bank of Canada dropped their price objective on Dr. Martens from GBX 7,000 ($94.70) to GBX 6,000 ($81.17) and set a “sector perform” rating for the company in a research note on Monday, May 19th.

Dr. Martens Stock Performance

The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The firm has a fifty day moving average price of GBX 55.34 and a two-hundred day moving average price of GBX 62.80. The stock has a market capitalization of £795.54 million, a PE ratio of 11.62, a P/E/G ratio of 6.40 and a beta of 0.11.

Dr. Martens (LON:DOCS) last issued its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current year.

Dr. Martens Cuts Dividend

The company also recently disclosed a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were issued a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date was Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens’s payout ratio is currently 42.53%.

Insiders Place Their Bets

In other news, insider Giles Wilson acquired 32,640 shares of Dr. Martens stock in a transaction on Tuesday, March 25th. The shares were bought at an average cost of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,844.16). Insiders have bought 33,206 shares of company stock worth $1,792,771 in the last ninety days. 4.36% of the stock is owned by company insiders.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.